IMMUNIC INC (IMUX) Stock Cash Flow
NASDAQ:IMUX - Nasdaq - US4525EP1011 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -96.40M | -100.51M | -93.61M | -120.41M | -92.95M | |||
| Depreciation Amortization | 151.00K | 134.00K | 111.00K | 80.00K | 90.00K | |||
| Change In Working Capital | 6.11M | 564.00K | 15.05M | 9.53M | -9.28M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 7.56M | 15.04M | 7.63M | 45.66M | 18.91M | |||
| OPERATING CASH FLOW | -82.57M | -84.77M | -70.83M | -65.14M | -83.23M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -280.00K | -264.00K | -334.00K | -110.00K | -70.00K | |||
| Other Investing Activity | N/A | 0.00 | 9.80M | -9.63M | N/A | |||
| INVESTING CASH FLOW | -280.00K | -264.00K | 9.46M | -9.74M | -70.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 77.00K | 268.00K | 1.03M | 95.76M | 42.84M | |||
| Other Financing Activity | 0.00 | 74.27M | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 77.00K | 74.54M | 1.03M | 95.76M | 42.84M | |||
| Exchange Rate Effect | -232.00K | -517.00K | 262.00K | -990.00K | -130.00K | |||
| CHANGE IN CASH | -83.01M | -11.01M | -60.07M | 19.89M | -40.59M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -82.57M | -84.77M | -70.83M | -65.14M | -83.23M | |||
| Capital Expenditure | -280.00K | -264.00K | -334.00K | -110.00K | -70.00K | |||
| FREE CASH FLOW | -82.85M | -85.03M | -71.16M | -65.25M | -83.30M | |||
All data in USD